The tweet was deleted by the author.
But we saved everything 🙂.
Wave Life Sciences plans to release its third quarter earnings update on October 27. The stock edges higher on the day, trading at $3.38.
Wave Life Sciences will deliver its third quarter earnings update on Tuesday, October 27. The company is inviting interested listeners to register and join the webcast for the event. Wave Life Sciences operates in the biotechnology sector, with 287 employees and a market capitalization of about $1.2 billion on revenue of $65.3 million over the trailing twelve months.
View post on X Loading...
Shares of Wave Life Sciences opened the session with a gap up at $3.42 from the previous close of $3.37, but have since given back part of those early gains. The broader daily chart remains bearish, as price continues to trade below its MA-20, MA-50, and MA-200. The nearest resistance sits at the weekly high of $3.49, and RSI at 37.5 is nearing oversold territory, suggesting the decline is getting stretched and may support some stabilization.
Traders should watch for a close above the weekly high at $3.49 to indicate buyers are willing to push higher. Price opened with a gap up from $3.37 to $3.42, with some of that move retracing as the session progressed. Even after a sustained move higher with a firm trend over the past week, the probabilities over the next five trading days are 28% for upside and 72% for downside, with an expected trading range between $3.19 and $3.56. A close below $3.08 would show the move is being faded. On the weekly chart the longer-term picture stays negative.
Earlier, analysts noted that Wave Life Sciences was under sustained bearish pressure despite developments in its clinical pipeline. With the technical outlook still tilted to the downside ahead of the company's earnings update, traders should monitor a close above $3.49 as a potential signal for renewed upward momentum.